Vaccines for Immune Mediated Diseases

 Patients with immune-mediated inflammatory diseases (IMID), for example, RA, IBD or psoriasis, are at expanded danger of contamination, in part in light of the ailment itself, yet for the most part on account of treatment with immune-modulatory or immunosuppressive drugs. Regardless of their raised hazard for vaccine-preventable disease, immunization inclusion in IMID patients is surprisingly low. Despite the fact that the decreased nature of the resistant reaction in patients under immunotherapy negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for <span background-attachment:="" background-clip:="" background-origin:="" background-position:="" background-repeat:="" background-size:="" hepatitis="" span="" style="" background-image:"="">Influenza and Pneumococcal vaccination Innate immunity and diabetes vaccines


  • Vaccines for immunodeficiency diseases
  • Vaccination strategy in patients with IMID
  • Vaccinations in patients with immune-mediated inflammatory diseases
  • Central nervous system-targeted & Tissue-specific autoimmunity
  • Vaccines for autoimmune skin disorders & neuropathies
  • Vaccine safety: impact on disease activity in IMID patients

Related Conference of Vaccines for Immune Mediated Diseases

March 18-19, 2019

33rdAnnual Vaccines & Vaccination Congress

New York, USA
March 18-19, 2019

35th World Vaccines & Immunization Congress

Novotel Brisbane, Australia
March 21-22, 2019

32nd International Conference on Vaccines and Immunization

Hotel Holiday Inn, Aurelia Rome, Italy
August 12-13, 2019

34th World Congress on Vaccines and Immunization

Auckland, New Zealand

Vaccines for Immune Mediated Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in